EMCURE Emcure Pharmaceuticals Ltd. — Smart-Money Activity, F&O Buildup & Bulk Deals
Sector: HealthcareLive setups screens EMCURE is on right now — tap to see every stock matching
Smart Money Verdict synthesis of derivatives, deals, and promoter files
Analysis what the data is telling us about EMCURE
Emcure Pharmaceuticals Ltd. did not have meaningful F&O activity in the last completed session. That doesn't mean the stock is irrelevant — it just means the smart-money signals here come from cash markets and corporate disclosures, covered below.
On the institutional side, Insurances are accumulating Emcure Pharmaceuticals Ltd. — the most recent notable was HDFC STANDARD LIFE INSURANCE COMPANY LTD on the buy side at ₹101 Cr.
Putting it together, the smart-money picture for Emcure Pharmaceuticals Ltd. is best read as range-bound for now.
F&O Positioning EOD derivatives setup
Quote Details key metrics & weights
Technical Snapshot from 400 sessions of price history
Key Fundamentals headline ratios · Healthcare
Fundamental ratios sourced from public market data, refreshed periodically; verify against company filings before relying on them.
Institutional Deals last 30 sessions (bulk & block)
| Date | Side | Price | Value (Cr) | Counterparty |
|---|---|---|---|---|
| 2026-06-25 | SELL | ₹ 1,817.00 | 176.20 | BC INVESTMENTS IV LIMITED |
| 2026-06-25 | SELL | ₹ 1,817.00 | 176.20 | BC INVESTMENTS IV LIMITED |
| 2026-06-25 | BUY | ₹ 1,817.00 | 101.20 | HDFC STANDARD LIFE INSURANCE COMPANY LTD Insurance |
| 2026-06-25 | BUY | ₹ 1,817.00 | 47.50 | ADITYA BIRLA SUN LIFE MUTUAL FUND MF |
| 2026-06-25 | BUY | ₹ 1,817.00 | 28.70 | HDFC STANDARD LIFE INSURNACE |
| 2026-06-25 | BUY | ₹ 1,817.00 | 25.00 | AXIS MUTUAL FUND MF |
| 2026-06-25 | BUY | ₹ 1,817.00 | 25.00 | ALPHA ALTERNATIVES EQUITY ABSOLUTE RETURN FUND |
| 2026-06-25 | BUY | ₹ 1,817.00 | 25.00 | BNP PARIBAS FINANCIAL MARKETS FII |
| 2026-06-25 | BUY | ₹ 1,817.00 | 25.00 | MORGAN STANLEY ASIA SINGAPORE PTE FII |
| 2026-06-25 | BUY | ₹ 1,817.00 | 25.00 | HSBC MUTUAL FUND MF |
Insider & Promoter Filings last 60 days
Latest News recent coverage from Reuters, Simply Wall St, MT Newswires and others
EMCURE — frequently asked questions
What is the Emcure Pharmaceuticals Ltd. share price today?
EMCURE is trading at ₹1,924.50 (+3.40% vs previous close), per the latest update on this page.
What is the P/E ratio of Emcure Pharmaceuticals Ltd.?
EMCURE (Emcure Pharmaceuticals Ltd.) has a trailing twelve-month P/E ratio of 39.5.
What is the market cap of Emcure Pharmaceuticals Ltd.?
EMCURE has a market capitalisation of approximately ₹36,504 crore.
What is the ROE of Emcure Pharmaceuticals Ltd.?
EMCURE has a return on equity (ROE) of about 19.6%.
Is EMCURE near its 52-week high?
EMCURE is trading -1.0% from its 52-week high of ₹1,944.00 as of 2026-07-21.
What is the RSI of EMCURE?
The 14-day RSI of EMCURE is 67.4, which is considered neutral.
Is EMCURE above its 200-day moving average?
EMCURE is trading above its 200-DMA of ₹1,548.58 (+24.3% away).
Are FIIs or big investors buying EMCURE?
Strota tracks every bulk and block deal in EMCURE with named buyers and sellers, plus promoter and insider filings — the tables on this page list the most recent institutional activity as disclosed to the exchanges.